Research Triangle Park, NC, United States of America

Jeffrey H Tidwell

This inventor holds 10 USPTO granted patents. Top assignees: Cenes Limited, Glaxo Wellcome Inc., Smithkline Beecham Corporation. Active years: 2001-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey H Tidwell. Retrieved from https://idiyas.com/inventor/jeffrey-h-tidwell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 70.0

Average Co-Inventor Count = 4.7

ph-index = 6

Forward Citations = 139(Granted Patents)


Location History:

  • Raleigh, NC (US) (2001 - 2003)
  • Durham, NC (US) (2007)
  • Research Triangle Park, NC (US) (2008 - 2009)

Company Filing History:


Years Active: 2001-2009

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Mind of Jeffrey H. Tidwell

Introduction: Jeffrey H. Tidwell, an accomplished inventor based in Research Triangle Park, NC, has made significant contributions to the field of pharmacology and therapeutics. With a total of 10 patents to his name, Tidwell has been instrumental in developing compounds that enhance medical care and patient outcomes.

Latest Patents: Among his notable inventions are his latest patents related to short-acting benzodiazepines. These compounds, characterized by a carboxylic ester moiety, have been shown to be inactivated by nonspecific tissue esterases, enabling organ-independent elimination. This innovative approach provides a more predictable and reproducible pharmacodynamic profile. His benzodiazepine derivatives are designed for various therapeutic applications, including sedative-hypnotic, anxiolytic, muscle relaxant, and anticonvulsant purposes. They are intended for intravenous administration in settings such as preoperative sedation, ICU sedation, and as components for the induction and maintenance of general anesthesia.

Career Highlights: Jeffrey H. Tidwell has had a dynamic career and has worked with several notable companies in the pharmaceutical industry. He has contributed his expertise to Cenes Limited and Glaxo Wellcome Inc., where he focused on advancing medical therapies through innovative drug development. His work in these esteemed companies has allowed him to significantly impact patient care.

Collaborations: Throughout his career, Tidwell has collaborated with esteemed colleagues, including Paul L. Feldman and David Kendall Jung. These partnerships have fostered an environment of innovation, enabling the development of groundbreaking therapies and fortifying the impact of their collective research.

Conclusion: Jeffrey H. Tidwell's contributions to the field of medicine through his numerous patents and collaborations exemplify the spirit of innovation. His work not only demonstrates his expertise as an inventor but also highlights the importance of collaborative efforts in advancing healthcare solutions. With his continued dedication, Tidwell remains a pivotal figure in the exploration of therapeutic drugs and the enhancement of medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…